518 related articles for article (PubMed ID: 19570496)
1. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey.
McIntyre RS
J Clin Psychiatry; 2009; 70 Suppl 3():5-11. PubMed ID: 19570496
[TBL] [Abstract][Full Text] [Related]
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
3. Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists.
Suppes T; McElroy SL; Hirschfeld R
Psychopharmacol Bull; 2007; 40(2):22-37; quiz 38-40. PubMed ID: 17514184
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
5. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
6. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
Altamura AC; Armadoros D; Jaeger M; Kernish R; Locklear J; Volz HP
Curr Med Res Opin; 2008 Aug; 24(8):2271-82. PubMed ID: 18588748
[TBL] [Abstract][Full Text] [Related]
7. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.
Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B
J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652
[TBL] [Abstract][Full Text] [Related]
8. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.
Hirschfeld RM; Lewis L; Vornik LA
J Clin Psychiatry; 2003 Feb; 64(2):161-74. PubMed ID: 12633125
[TBL] [Abstract][Full Text] [Related]
9. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
10. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
Torrent C; Amann B; Sánchez-Moreno J; Colom F; Reinares M; Comes M; Rosa AR; Scott J; Vieta E
Acta Psychiatr Scand; 2008 Jul; 118(1):4-18. PubMed ID: 18498432
[TBL] [Abstract][Full Text] [Related]
11. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
[TBL] [Abstract][Full Text] [Related]
12. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
13. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
14. Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists.
Bauer M; Lecrubier Y; Suppes T
Eur Psychiatry; 2008 Apr; 23(3):169-77. PubMed ID: 18160267
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
16. GAMIAN-Europe/BEAM survey II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style.
Morselli PL; Elgie R; Cesana BM
Bipolar Disord; 2004 Dec; 6(6):487-97. PubMed ID: 15541064
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey.
McIntyre RS; Konarski JZ; Wilkins K; Bouffard B; Soczynska JK; Kennedy SH
Headache; 2006 Jun; 46(6):973-82. PubMed ID: 16732843
[TBL] [Abstract][Full Text] [Related]
19. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders.
Morgan VA; Mitchell PB; Jablensky AV
Bipolar Disord; 2005 Aug; 7(4):326-37. PubMed ID: 16026485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
